Kalvista Pharmaceuticals Inc (KALV) PT Raised to $37 at BofA Securities
Tweet Send to a Friend
BofA Securities analyst Tazeen Ahmad raised the price target on Kalvista Pharmaceuticals Inc (NASDAQ: KALV) to $37.00 (from $22.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
